- Report
- October 2024
- 200 Pages
Global
From €3323EUR$3,750USD£2,844GBP
- Report
- January 2024
- 200 Pages
Global
From €3677EUR$4,150USD£3,147GBP
- Report
- July 2024
- 150 Pages
Global
From €3323EUR$3,750USD£2,844GBP
- Report
- July 2024
- 150 Pages
Global
From €3323EUR$3,750USD£2,844GBP
- Report
- July 2024
- 150 Pages
Global
From €3323EUR$3,750USD£2,844GBP
- Report
- May 2023
- 120 Pages
Global
From €3987EUR$4,500USD£3,413GBP
- Report
- May 2025
- 115 Pages
Global
From €4209EUR$4,750USD£3,602GBP
- Report
- July 2024
- 120 Pages
Global
From €4209EUR$4,750USD£3,602GBP
- Report
- July 2025
- 350 Pages
Global
From €4385EUR$4,949USD£3,753GBP
- Report
- July 2025
- 350 Pages
Global
From €4385EUR$4,949USD£3,753GBP
- Report
- June 2025
- 400 Pages
Global
From €4385EUR$4,949USD£3,753GBP
- Report
- June 2025
- 250 Pages
United States
From €2471EUR$2,789USD£2,115GBP
- Report
- June 2025
- 250 Pages
India
From €2471EUR$2,789USD£2,115GBP
- Report
- October 2024
- 200 Pages
Global
From €4385EUR$4,949USD£3,753GBP
- Report
- December 2024
- 146 Pages
Global
From €3500EUR$3,950USD£2,996GBP
From €3190EUR$3,600USD£2,730GBP
- Report
- May 2024
North America
From €1329EUR$1,500USD£1,138GBP
- Report
- May 2024
Asia Pacific
From €1329EUR$1,500USD£1,138GBP
- Report
- May 2024
Middle East, Africa
From €1329EUR$1,500USD£1,138GBP
- Report
- May 2025
- 175 Pages
Europe
From €3101EUR$3,500USD£2,654GBP

A diagnostic biomarker is a biological molecule or gene that is used to identify a particular disease or condition. It is used to diagnose, monitor, and predict the progression of a disease or condition. Diagnostic biomarkers are used to detect the presence of a disease or condition, to determine the severity of the disease or condition, and to monitor the effectiveness of treatments. Diagnostic biomarkers are used in a variety of medical fields, including oncology, neurology, cardiology, and infectious diseases.
Diagnostic biomarkers are typically identified through a variety of methods, including genetic sequencing, proteomics, and metabolomics. These methods allow for the identification of biomarkers that are specific to a particular disease or condition.
The diagnostic biomarker market is a rapidly growing field, with many companies developing and marketing diagnostic biomarkers. Companies in this market include Illumina, Thermo Fisher Scientific, Qiagen, Roche, and Agilent Technologies. Show Less Read more